However, in the late stages of cancer, TAMs start to secrete IL-10, TGF-β, and IL-12 as previously mentioned, suppressing cytotoxic T lymphocyte (CTL) and NK cells and thus having anti-inflammatory action [3]. The gene discussed is TGFB1; the disease is cancer.